Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Oncometabolites: A New Insight for Oncology Publisher Pubmed



Khatami F1 ; Aghamir SMK1 ; Tavangar SM2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Molecular Genetics and Genomic Medicine Published:2019


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
2. The Emerging Role of Succinate Dehyrogenase Genes (Sdhx) in Tumorigenesis, International Journal of Hematology-Oncology and Stem Cell Research (2019)
3. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Tavangar (20)
Bagher Larijani (9)
Other Related Docs
4. Oncometabolites As Biomarkers in Thyroid Cancer: A Systematic Review, Cancer Management and Research (2019)
5. The Impact of Succinate Dehydrogenase Gene (Sdh) Mutations in Renal Cell Carcinoma (Rcc): A Systematic Review, OncoTargets and Therapy (2019)
6. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
7. Hypermethylated Rassf1 and Slc5a8 Promoters Alongside Brafv600e Mutation As Biomarkers for Papillary Thyroid Carcinoma, Journal of Cellular Physiology (2020)
8. Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report, International Journal of Hematology-Oncology and Stem Cell Research (2018)
9. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
10. Genetic and Epigenetic Differences of Benign and Malignant Pheochromocytomas and Paragangliomas (Ppgls), Endocrine Regulations (2018)
11. The Presence of Tumor Extrachomosomal Circular Dna (Ecdna) As a Component of Liquid Biopsy in Blood, Medical Hypotheses (2018)
12. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
13. Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review, Iranian Journal of Pathology (2017)
14. Multiple Endocrine Neoplasia Syndromes From Genetic and Epigenetic Perspectives, Biomarker Insights (2018)
15. Circulating Ctdna Methylation Quantification of Two Dna Methyl Transferases in Papillary Thyroid Carcinoma, Journal of Cellular Biochemistry (2019)
16. Low Expression of Isocitrate Dehydrogenase 1 (Idh1) R132h Is Associated With Advanced Pathological Features in Laryngeal Squamous Cell Carcinoma, Journal of Cancer Research and Clinical Oncology (2023)
17. Meta-Analysis of Promoter Methylation in Eight Tumor-Suppressor Genes and Its Association With the Risk of Thyroid Cancer, PLoS ONE (2017)
18. Genetic and Epigenetic of Medullary Thyroid Cancer, Iranian Biomedical Journal (2018)
19. A Review of Driver Genetic Alterations in Thyroid Cancers, Iranian Journal of Pathology (2018)
20. Dyspnea As the First Manifestation of Silent Renal Cell Carcinoma, Iranian Journal of Pathology (2019)
21. Clear Cell Sarcoma: A Case Report and Review of Literature, International Journal of Hematology-Oncology and Stem Cell Research (2018)
22. Thyroid Cancer Research at Endocrinology and Metabolism Research Institute (Emri): A Report of Scientific Activities Between 2005 and 2020, Journal of Diabetes and Metabolic Disorders (2021)